Invention Grant
- Patent Title: Fusion proteins containing a BDNF and an anti-human transferrin receptor antibody
-
Application No.: US17349414Application Date: 2021-06-16
-
Publication No.: US11958905B2Publication Date: 2024-04-16
- Inventor: Hiroyuki Sonoda , Kenichi Takahashi
- Applicant: JCR Pharmaceuticals Co., Ltd.
- Applicant Address: JP Hyogo
- Assignee: JCR Pharmaceuticals Co., Ltd.
- Current Assignee: JCR Pharmaceuticals Co., Ltd.
- Current Assignee Address: JP Hyogo
- Agency: Morgan, Lewis & Bockius LLP
- Priority: JP 15144380 2015.06.24
- The original application number of the division: US15739199
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K38/18 ; A61K38/22 ; A61K39/395 ; A61P25/00 ; A61P25/28 ; C07K14/475 ; C07K14/48 ; C07K16/00 ; C07K16/28 ; C07K19/00 ; C12N5/10 ; C12N15/00 ; C12N15/09 ; C12N15/52 ; C12N15/62 ; C12N15/63 ; A61K39/00
Abstract:
Disclosed is a fusion protein containing a brain-derived neurotrophic factor (BDNF). The fusion protein is a fusion protein of BDNF and a specific range of human anti-transferrin receptor antibody, which makes BDNF administered into the blood able to pass through the blood-brain barrier.
Public/Granted literature
- US20210309754A1 Fusion Protein Containing BDNF Public/Granted day:2021-10-07
Information query
